What We Do

Exploring Nervous System Health via Nutritional and Endocannabinoid Pathways

The recent advancements in gene sequencing, medical nutrition and phytocannabinoid research has revealed new opportunities for the development of novel therapies and clinical protocols designed to improve the way chronic disease is treated.

Medical Foods plus CBDEndocannabinoid System's Role in and Cellular Communications

The endocannabinoid system (ECS) is a major component of the human nervous system influencing cell to cell communication, along with biological functions such as appetite, anxiety, learning and memory, reproduction, metabolism, growth and development. The ECS also plays a significant role in regulating pain and inflammatory processes through its influence on branches of the central nervous system.

Phytocannabinoids such as Cannabidiol (CBD) or tetrahydrocannabinol (THC) are a class of natural compounds that affect neurotransmitter release in the brain and central nervous system. These products are increasingly becoming adopted as standalone and complimentary treatment options for people suffering with chronic health conditions such as pain syndromes, sleep disorders, PTSD, metabolic syndrome, and obesity.

CBD and THC affect neurotransmitter release in the brain and central nervous system.

Targeted Medical Pharma is committed to the development of products and clinical protocols capable of improving nervous system health via nutritional and endocannabinoid pathways using genetic sequencing technology to further the research into the symbiotic relationship of medical nutrition and phytocannabinoids.

  1. Kendall DA, Yudowski GA. Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease. Front Cell Neurosci. 2017;10:294. Published 2017 Jan 4. doi:10.3389/fncel.2016.00294
  2. Kendall, Debra A and Guillermo A Yudowski. “Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease” Frontiers in cellular neuroscience vol. 10 294. 4 Jan. 2017, doi:10.3389/fncel.2016.00294
  3. French, E. D., Dillon, K., and Wu, X. (1997). Cannabinoids excite dopamine neurons in the ventral tegmentum and Substantia nigra. Neuroreport 8, 649–652. doi: 10.1097/00001756-199702100-00014
  4. Han, J., Kesner, P., Metna-Laurent, M., Duan, T., Xu, L., Georges, F., et al. (2012). Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell 148, 1039–1050. doi: 10.1016/j.cell.2012.01.037